DE3751004D1 - Chimärer Antikörper mit Spezifität für menschliches Tumor-Antigen. - Google Patents
Chimärer Antikörper mit Spezifität für menschliches Tumor-Antigen.Info
- Publication number
- DE3751004D1 DE3751004D1 DE3751004T DE3751004T DE3751004D1 DE 3751004 D1 DE3751004 D1 DE 3751004D1 DE 3751004 T DE3751004 T DE 3751004T DE 3751004 T DE3751004 T DE 3751004T DE 3751004 D1 DE3751004 D1 DE 3751004D1
- Authority
- DE
- Germany
- Prior art keywords
- chimeric antibody
- tumor antigen
- human tumor
- antibody specific
- human
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57446—Specifically defined cancers of stomach or intestine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Details Of Garments (AREA)
- Luminescent Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92324486A | 1986-10-27 | 1986-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3751004D1 true DE3751004D1 (de) | 1995-03-02 |
DE3751004T2 DE3751004T2 (de) | 1995-05-24 |
Family
ID=25448370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3751004T Expired - Fee Related DE3751004T2 (de) | 1986-10-27 | 1987-10-27 | Chimärer Antikörper mit Spezifität für menschliches Tumor-Antigen. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5354847A (de) |
EP (1) | EP0266663B1 (de) |
JP (1) | JPH02501886A (de) |
AT (1) | ATE117370T1 (de) |
AU (2) | AU626254B2 (de) |
DE (1) | DE3751004T2 (de) |
ES (1) | ES2069527T3 (de) |
FI (1) | FI891984A (de) |
GR (1) | GR3015810T3 (de) |
HU (1) | HU209154B (de) |
IE (1) | IE62304B1 (de) |
IL (1) | IL84285A (de) |
NZ (1) | NZ222309A (de) |
OA (1) | OA09115A (de) |
PT (1) | PT85995B (de) |
WO (1) | WO1988003145A1 (de) |
ZA (1) | ZA878044B (de) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5576195A (en) * | 1985-11-01 | 1996-11-19 | Xoma Corporation | Vectors with pectate lyase signal sequence |
US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
US6893625B1 (en) | 1986-10-27 | 2005-05-17 | Royalty Pharma Finance Trust | Chimeric antibody with specificity to human B cell surface antigen |
IL85035A0 (en) * | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
CA1341235C (en) * | 1987-07-24 | 2001-05-22 | Randy R. Robinson | Modular assembly of antibody genes, antibodies prepared thereby and use |
GB8720833D0 (en) * | 1987-09-04 | 1987-10-14 | Celltech Ltd | Recombinant dna product |
US5336603A (en) * | 1987-10-02 | 1994-08-09 | Genentech, Inc. | CD4 adheson variants |
US6710169B2 (en) | 1987-10-02 | 2004-03-23 | Genentech, Inc. | Adheson variants |
US5576184A (en) * | 1988-09-06 | 1996-11-19 | Xoma Corporation | Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
EP0364096B1 (de) | 1988-09-06 | 2000-03-08 | Xoma Corporation | Genexpressions-Elemente und Herstellung von chimären Maus-Mensch-Antikörpern |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
DE3900534A1 (de) * | 1989-01-10 | 1990-07-12 | Boehringer Mannheim Gmbh | Diagnostischer nachweis unter verwendung von chimaeren antikoerpern |
DK0460076T3 (da) * | 1989-02-24 | 1996-03-25 | Univ California | Genetisk manipulerede immunoglobuliner |
DE3909799A1 (de) * | 1989-03-24 | 1990-09-27 | Behringwerke Ag | Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung |
US5580774A (en) * | 1989-07-31 | 1996-12-03 | Eli Lilly And Company | Chimeric antibodies directed against a human glycoprotein antigen |
US20050196400A1 (en) * | 1991-05-06 | 2005-09-08 | Xoma Technology Ltd. | Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
AU669124B2 (en) * | 1991-09-18 | 1996-05-30 | Kyowa Hakko Kirin Co., Ltd. | Process for producing humanized chimera antibody |
US5635177A (en) | 1992-01-22 | 1997-06-03 | Genentech, Inc. | Protein tyrosine kinase agonist antibodies |
US5543499A (en) * | 1993-10-29 | 1996-08-06 | Wake Forest University | DNA sequence encoding a polypeptide with anti-tumor properties |
US5877016A (en) | 1994-03-18 | 1999-03-02 | Genentech, Inc. | Human trk receptors and neurotrophic factor inhibitors |
US5817768A (en) * | 1995-06-07 | 1998-10-06 | The New York Blood Center, Inc. | Monospecific antibodies against a subunit of fibrinogen |
US6100071A (en) | 1996-05-07 | 2000-08-08 | Genentech, Inc. | Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production |
DK0966533T3 (da) | 1997-02-07 | 2010-01-04 | Us Gov Health & Human Serv | Aktivitetsafhængig neurotrof faktor III (ADNF III). |
US6946129B1 (en) | 1999-06-08 | 2005-09-20 | Seattle Genetics, Inc. | Recombinant anti-CD40 antibody and uses thereof |
EP1438400B1 (de) | 2001-10-01 | 2009-06-17 | Dyax Corp. | Mehrkettige eukaryontische display-vektoren und deren verwendungen |
US7306919B1 (en) | 2001-10-31 | 2007-12-11 | Thornthwaite Jerry T | Antigen-antibody cancer recognition system |
US7332585B2 (en) | 2002-04-05 | 2008-02-19 | The Regents Of The California University | Bispecific single chain Fv antibody molecules and methods of use thereof |
CA2489595C (en) * | 2002-06-14 | 2013-05-28 | Simon E. Hufton | Recombination of nucleic acid library members |
WO2005016232A2 (en) | 2002-08-01 | 2005-02-24 | The Regents Of The University Of California | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
US20040156846A1 (en) * | 2003-02-06 | 2004-08-12 | Triton Biosystems, Inc. | Therapy via targeted delivery of nanoscale particles using L6 antibodies |
AU2003901511A0 (en) * | 2003-03-28 | 2003-04-17 | Bionomics Limited | Nucleic acid molecules associated with angiogenesis II |
US20110064730A1 (en) * | 2003-03-28 | 2011-03-17 | Thomas John Gonda | Method of modulating angiogenesis |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
WO2005059176A1 (en) * | 2003-12-15 | 2005-06-30 | Institut Pasteur | Repertoire determination of a lymphocyte b population |
DE60326052D1 (de) * | 2003-12-15 | 2009-03-19 | Pasteur Institut | Ermittlung des Repertoires von B-Lymphozyten Populationen |
EP2213683B1 (de) | 2004-08-04 | 2013-06-05 | Mentrik Biotech, LLC | Varianten der Fc Regionen |
RU2432962C2 (ru) | 2005-01-27 | 2011-11-10 | Чилдрен'З Хоспитал Энд Рисерч Сентер Эт Окленд | Вакцины с использованием везикул на основе gna 1870 широкого спектра действия для профилактики заболеваний, вызываемых neisseria meningitidis |
WO2007094754A2 (en) | 2005-01-27 | 2007-08-23 | The Regents Of The University Of Califordnia | Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
JP5238936B2 (ja) | 2005-03-25 | 2013-07-17 | ジーアイティーアール,インク. | Gitr結合分子およびその使用 |
AU2006249305B2 (en) | 2005-05-26 | 2012-10-18 | Genentech, Inc. | Humanized anti-CD40 antibodies and their methods of use |
US8901281B2 (en) | 2005-06-17 | 2014-12-02 | Merck Sharp & Dohme Corp. | ILT3 binding molecules and uses therefor |
US7777008B2 (en) | 2006-06-19 | 2010-08-17 | Tolerx, Inc. | ILT3 binding molecules and uses therefor |
US20080213170A1 (en) * | 2007-01-23 | 2008-09-04 | Young David S F | Cancerous Disease Modifying Antibodies |
US8003761B2 (en) | 2007-01-23 | 2011-08-23 | Hoffmann-La Roche Inc. | Cancerous disease modifying antibodies |
JP5932217B2 (ja) | 2007-07-12 | 2016-06-08 | ジーアイティーアール, インコーポレイテッド | Gitr結合分子を使用する併用療法 |
CA2699394C (en) | 2007-09-17 | 2020-03-24 | The Regents Of The University Of California | Internalizing human monoclonal antibodies targeting prostate cancer cells in situ |
US8277651B2 (en) | 2009-03-13 | 2012-10-02 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
KR20140002601A (ko) | 2010-07-09 | 2014-01-08 | 바이오겐 이데크 헤모필리아 인코포레이티드 | 키메라 응고 인자 |
CA2809363A1 (en) | 2010-08-24 | 2012-03-01 | Abbott Laboratories | Hiv core protein specific antibodies and uses thereof |
EP3527218A1 (de) | 2011-06-10 | 2019-08-21 | Bioverativ Therapeutics Inc. | Gerinnungsfördernde verbindungen und verfahren zur verwendung davon |
WO2013012733A1 (en) | 2011-07-15 | 2013-01-24 | Biogen Idec Ma Inc. | Heterodimeric fc regions, binding molecules comprising same, and methods relating thereto |
AU2013207927B2 (en) | 2012-01-10 | 2017-11-02 | Biogen Ma Inc. | Enhancement of transport of therapeutic molecules across the blood brain barrier |
US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
WO2014093417A1 (en) | 2012-12-12 | 2014-06-19 | University Of Virginia Patent Foundation | Compositions and methods for regulating erythropoiesis |
EP3683314A1 (de) * | 2013-10-07 | 2020-07-22 | Prestige Biopharma Pte. Ltd. | Bicistronischer expressionsvektor zur antikörperexpression und verfahren zur antikörperherstellung damit |
WO2015070014A1 (en) | 2013-11-08 | 2015-05-14 | Biogen Idec Ma Inc. | Procoagulant fusion compound |
PT3383920T (pt) | 2015-11-30 | 2024-04-15 | Univ California | Entrega de carga útil específica para tumores e ativação imune utilizando um anticorpo humano que tem como alvo um antigénio altamente específico da superfície das células tumorais |
US10995126B2 (en) | 2016-05-04 | 2021-05-04 | National Health Research Institutes | Immunogenic peptide containing a b cell epitope of tumor associated antigen L6 |
WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
US11932650B2 (en) | 2017-05-11 | 2024-03-19 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
WO2019018744A1 (en) | 2017-07-21 | 2019-01-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | IMMUNOGENIC COMPOSITIONS OF NEISSERIA MENINGITIDIS |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
US20200283537A1 (en) | 2017-11-14 | 2020-09-10 | University Of Virginia Patent Foundation | Compositions and methods for making and using bispecific antibodies |
CN116419747A (zh) | 2020-08-07 | 2023-07-11 | 福蒂斯治疗公司 | 靶向cd46的免疫偶联物及其使用方法 |
WO2022182415A1 (en) | 2021-02-24 | 2022-09-01 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4468464A (en) * | 1974-11-04 | 1984-08-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically functional molecular chimeras |
US4486538A (en) * | 1978-07-07 | 1984-12-04 | Samuel Bogoch | Detection of malignant tumor cells |
US4650756A (en) * | 1981-08-31 | 1987-03-17 | Sloan Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human renal cancer |
US4476538A (en) * | 1982-02-01 | 1984-10-09 | Analog Devices, Inc. | Trigonometric function generator |
DE3369466D1 (en) * | 1982-05-12 | 1987-03-05 | Harvard College | Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof |
US4708862A (en) * | 1983-02-22 | 1987-11-24 | Xoma Corporation | Radioimmuno detection of human cancers using anti-tumor monoclonal antibody |
GB8308235D0 (en) * | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4550756A (en) * | 1984-01-16 | 1985-11-05 | The Goodyear Tire & Rubber Company | Pneumatic tire tread |
JPS6147500A (ja) * | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
EP0173494A3 (de) * | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimäre Rezeptoren durch Verbindung und Expression von DNS |
GB8422238D0 (en) * | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
JPS61134325A (ja) * | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
US4906562A (en) * | 1984-12-21 | 1990-03-06 | Oncogen | Monocolonal antibodies and antigen for human non-small cell lung carcinomas |
US4770993A (en) * | 1985-10-31 | 1988-09-13 | Beatrice Companies, Inc. | Hybridoma tumor cell lines and their monoclonal antibodies to thaumatin |
EP0247091B1 (de) * | 1985-11-01 | 1993-09-29 | Xoma Corporation | Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung |
US5091178A (en) * | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
-
1987
- 1987-10-26 IL IL84285A patent/IL84285A/xx not_active IP Right Cessation
- 1987-10-27 HU HU876038A patent/HU209154B/hu not_active IP Right Cessation
- 1987-10-27 WO PCT/US1987/002832 patent/WO1988003145A1/en active Application Filing
- 1987-10-27 ES ES87115769T patent/ES2069527T3/es not_active Expired - Lifetime
- 1987-10-27 IE IE288087A patent/IE62304B1/en not_active IP Right Cessation
- 1987-10-27 NZ NZ222309A patent/NZ222309A/xx unknown
- 1987-10-27 ZA ZA878044A patent/ZA878044B/xx unknown
- 1987-10-27 AT AT87115769T patent/ATE117370T1/de not_active IP Right Cessation
- 1987-10-27 JP JP62507134A patent/JPH02501886A/ja active Pending
- 1987-10-27 EP EP87115769A patent/EP0266663B1/de not_active Expired - Lifetime
- 1987-10-27 AU AU83261/87A patent/AU626254B2/en not_active Ceased
- 1987-10-27 PT PT85995A patent/PT85995B/pt not_active IP Right Cessation
- 1987-10-27 DE DE3751004T patent/DE3751004T2/de not_active Expired - Fee Related
-
1989
- 1989-04-25 OA OA59567A patent/OA09115A/xx unknown
- 1989-04-26 FI FI891984A patent/FI891984A/fi not_active Application Discontinuation
-
1991
- 1991-09-12 US US07/759,707 patent/US5354847A/en not_active Expired - Lifetime
-
1992
- 1992-11-02 AU AU28105/92A patent/AU656633B2/en not_active Ceased
-
1995
- 1995-04-17 GR GR950400940T patent/GR3015810T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
IL84285A0 (en) | 1988-03-31 |
JPH02501886A (ja) | 1990-06-28 |
AU626254B2 (en) | 1992-07-30 |
GR3015810T3 (en) | 1995-07-31 |
HUT52153A (en) | 1990-06-28 |
FI891984A0 (fi) | 1989-04-26 |
AU8326187A (en) | 1988-05-25 |
AU656633B2 (en) | 1995-02-09 |
IL84285A (en) | 1993-03-15 |
WO1988003145A1 (en) | 1988-05-05 |
ZA878044B (en) | 1988-04-25 |
FI891984A (fi) | 1989-04-26 |
US5354847A (en) | 1994-10-11 |
IE62304B1 (en) | 1995-01-25 |
DE3751004T2 (de) | 1995-05-24 |
EP0266663B1 (de) | 1995-01-18 |
PT85995B (pt) | 1990-08-31 |
HU209154B (en) | 1994-03-28 |
IE872880L (en) | 1988-04-27 |
EP0266663A1 (de) | 1988-05-11 |
NZ222309A (en) | 1990-02-26 |
PT85995A (en) | 1987-11-01 |
ES2069527T3 (es) | 1995-05-16 |
OA09115A (en) | 1991-10-31 |
ATE117370T1 (de) | 1995-02-15 |
AU2810592A (en) | 1993-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3751004D1 (de) | Chimärer Antikörper mit Spezifität für menschliches Tumor-Antigen. | |
GR3033630T3 (en) | Gene expression elements and the production of chimeric mouse-human antibodies. | |
PT86792A (pt) | Monoclonal antibodies against melanoma-associated antigens hybrid cell lines producing these antibodies and use therefor | |
EP0274394A3 (de) | Chimären Antikörper, spezifisch für menschlichen B-Zellen-Oberflächenantigen | |
ATE112802T1 (de) | Herstellung von funktionellen menschlichen urokinasepolypeptiden. | |
ATE113845T1 (de) | Monoklonale antikörper gegen glycolipid-antigene und ihre verwendung. | |
NO861577L (no) | Antigen, antistoff og fremgangsmaate for dets fremstilling og anvendelse derav for diagnostisering. | |
EP0404003A3 (de) | Chimäre Maus-Mensch-KM10-Antikörper, spezifisch für ein menschliches Tumorzellen-Antigen | |
EP0338395A3 (en) | Monoclonal antibodies to pseudomonas aeruginosa, their production and use | |
EP0287397A3 (en) | Monoclonal antibody specific to human pancreatic phospholipase a2 | |
DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
DE3579808D1 (de) | Anti-urokinase monoklonaler antikoerper, seine herstellung und verwendung. | |
ATE86261T1 (de) | Tumorassoziiertes antigen. | |
ATE92081T1 (de) | Tumorassoziiertes antigen. | |
DK354288A (da) | Kimaert antistof med specificitet over for humant tumorantigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |